503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
1.33%
Revenue growth below 50% of CRWD's 8.96%. Michael Burry would check for competitive disadvantage risks.
2.11%
Cost growth less than half of CRWD's 7.53%. David Dodd would verify if cost advantage is structural.
0.98%
Gross profit growth below 50% of CRWD's 9.43%. Michael Burry would check for structural issues.
-0.34%
Margin decline while CRWD shows 0.43% expansion. Joel Greenblatt would examine competitive position.
-6.36%
R&D reduction while CRWD shows 9.93% growth. Joel Greenblatt would examine competitive risk.
-25.51%
G&A reduction while CRWD shows 0.97% growth. Joel Greenblatt would examine efficiency advantage.
-16.12%
Marketing expense reduction while CRWD shows 20.58% growth. Joel Greenblatt would examine competitive risk.
100.00%
Similar other expenses growth to CRWD's 111.73%. Walter Schloss would investigate industry patterns.
-12.76%
Operating expenses reduction while CRWD shows 13.90% growth. Joel Greenblatt would examine advantage.
-4.81%
Total costs reduction while CRWD shows 12.26% growth. Joel Greenblatt would examine advantage.
-16.98%
Interest expense reduction while CRWD shows 1.39% growth. Joel Greenblatt would examine advantage.
15.72%
Similar D&A growth to CRWD's 14.90%. Walter Schloss would investigate industry patterns.
11.45%
EBITDA growth while CRWD declines. John Neff would investigate advantages.
10.00%
EBITDA margin growth while CRWD declines. John Neff would investigate advantages.
9.41%
Operating income growth while CRWD declines. John Neff would investigate advantages.
7.98%
Operating margin growth while CRWD declines. John Neff would investigate advantages.
58.07%
Other expenses growth while CRWD reduces costs. John Neff would investigate differences.
11.08%
Pre-tax income growth while CRWD declines. John Neff would investigate advantages.
9.63%
Pre-tax margin growth while CRWD declines. John Neff would investigate advantages.
7.44%
Tax expense growth while CRWD reduces burden. John Neff would investigate differences.
11.94%
Net income growth while CRWD declines. John Neff would investigate advantages.
10.48%
Net margin growth while CRWD declines. John Neff would investigate advantages.
12.16%
EPS growth while CRWD declines. John Neff would investigate advantages.
11.86%
Diluted EPS growth while CRWD declines. John Neff would investigate advantages.
No Data
No Data available this quarter, please select a different quarter.
-0.03%
Diluted share reduction while CRWD shows 0.90% change. Joel Greenblatt would examine strategy.